Sponsor pipeline

ADARx Pharmaceuticals, Inc. clinical trial pipeline

Get alerts when ADARx Pharmaceuticals, Inc.'s trials change

9 active trials 7 recruiting 2 Phase 3 1 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

Active trials by phase

Phase 1
2
Phase 1/2
2
Phase 2
3
Phase 3
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT06960213 STOP-HAE: A Phase 3 Study of ADX-324 in HAE Hereditary Angioedema Recruiting 2026-09-10
NCT07428499 Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE) Hereditary Angioedema (HAE) Recruiting 2026-09-04
Phase 2
NCT06989359 Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease IgAN Recruiting 2026-09-03
NCT06990269 Phase 2 Study of ADX-038 in Participants With Geographic Atrophy Geographic Atrophy Secondary to Age-related Macular Degeneration Recruiting 2026-09-03
NCT07522099 Chinese Adults With Kidney Disease Immunoglobulin A Nephropathy (IgAN) Recruiting 2026-09-03
Phase 1/2
NCT05876312 Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal… Paroxysmal Nocturnal Hemoglobinuria (PNH) Recruiting 2026-06-16
NCT05691361 Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema… Hereditary Angioedema Active, Not Recruiting 2026-06-16
Phase 1
NCT07081503 Phase 1 Study of ADX-626 in Healthy Participants Healthy Adult Participants Recruiting 2026-09-10
NCT06205628 Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension Hypertension Active, Not Recruiting 2026-09-03

Disease areas by active trials

Hypertension (1)

Get alerts when ADARx Pharmaceuticals, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free